Trials / Conditions / Nasal Type Extranodal NK/T-Cell Lymphoma
Nasal Type Extranodal NK/T-Cell Lymphoma
4 registered clinical trials studyying Nasal Type Extranodal NK/T-Cell Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma NCT04096690 | Ruijin Hospital | Phase 2 |
| Completed | Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma NCT02652715 | Mayo Clinic | N/A |
| Completed | Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma NCT02825147 | Ruijin Hospital | Phase 2 |
| Active Not Recruiting | Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency NCT01787409 | Mayo Clinic | N/A |